FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2889968197> ?p ?o ?g. }

• W2889968197 abstract "TPS4601 Background: In the cytokine era cytoreductive nephrectomy (CN) has been shown to increase survival in patients (pts) with metastatic renal cell carcinoma (mRCC). Efficacy of tyrosine kinase inhibitors (TKIs), including first-line sunitinib and pazopanib has been demonstrated. It is unclear if similar survival benefit could be achieved without CN with TKIs since most of pts enrolled into phase III trials had undergone CN. Methods: A total of 270 mRCC pts will be randomized to receiveCN followed by TKIs vs upfront TKIs without CN. Patients will receive pazopanib 800 mg orally daily or sunitinib 50 mg daily, 4 weeks on/ 2 weeks off. The choice of TKI will be done according to investigator’s clinical practice. Primary objective: to compare clinical benefit, as measured by overall survival (OS), provided by CN followed by TKIs vs upfront TKIs in pts with mRCC. Secondary objectives: i) to compare clinical benefit, as measured by progression-free survival (PFS) and response rate (RR) provided by CN followed by TKIs vs upfront TKIs; ii) Safety; iii) Exploratory analyses: evaluation of the predictive role of circulating tumor cells count and circulating tumor DNA at baseline, before and after surgery (in pts undergoing CN), 24 weeks after randomization and at the time of disease progression. Key inclusion criteria: Favorable or intermediate MSKCC or Heng prognostic risk group; histological diagnosis of RCC with a clear-cell component; resectable asymptomatic mRCC with primary tumor in place; up to three different metastatic sites; ≥ 3 metastatic lesions. Key exclusion criteria: Widespread disease ( > or = 4 metastatic organ sites); disease suitable of metastasectomy ( < 3 lesions confined at one organ site). Statistical plan: The sample size was calculated in order to compare 5-year OS between subjects randomized to receive CN followed by TKIs and those randomized to receive upfront TKIs. A total of 191 deaths will yield 80% power to detect a hazard ratio of 1.5 of upfront TKIs vs CN followed by TKIs with an overall type 1 error of 0.05 (two-sided log-rank test). Such a HR corresponds to an increase in the 5-year OS, from an anticipated value of 10% for TKIs to 21.5% for CN followed by TKIs. To date 10/270 pts have been enrolled. Clinical trial information: NCT02535351." @default.
• W2889968197 created "2018-09-27" @default.
• W2889968197 creator A5005319110 @default.
• W2889968197 creator A5008166009 @default.
• W2889968197 creator A5013913173 @default.
• W2889968197 creator A5016673044 @default.
• W2889968197 creator A5025486410 @default.
• W2889968197 creator A5026639715 @default.
• W2889968197 creator A5029935476 @default.
• W2889968197 creator A5053179795 @default.
• W2889968197 creator A5055173181 @default.
• W2889968197 creator A5057926104 @default.
• W2889968197 creator A5061095811 @default.
• W2889968197 creator A5067193136 @default.
• W2889968197 creator A5071060598 @default.
• W2889968197 creator A5080811290 @default.
• W2889968197 creator A5081355165 @default.
• W2889968197 creator A5082094987 @default.
• W2889968197 creator A5084629809 @default.
• W2889968197 creator A5088690292 @default.
• W2889968197 creator A5089708987 @default.
• W2889968197 creator A5091765229 @default.
• W2889968197 date "2017-05-20" @default.
• W2889968197 modified "2023-10-17" @default.
• W2889968197 title "TARIBO trial: Cytoreductive nephrectomy in metastatic renal cell carcinoma patients treated with targeted agents." @default.
• W2889968197 doi "https://doi.org/10.1200/jco.2017.35.15_suppl.tps4601" @default.
• W2889968197 hasPublicationYear "2017" @default.
• W2889968197 type Work @default.
• W2889968197 sameAs 2889968197 @default.
• W2889968197 citedByCount "0" @default.
• W2889968197 crossrefType "journal-article" @default.
• W2889968197 hasAuthorship W2889968197A5005319110 @default.
• W2889968197 hasAuthorship W2889968197A5008166009 @default.
• W2889968197 hasAuthorship W2889968197A5013913173 @default.
• W2889968197 hasAuthorship W2889968197A5016673044 @default.
• W2889968197 hasAuthorship W2889968197A5025486410 @default.
• W2889968197 hasAuthorship W2889968197A5026639715 @default.
• W2889968197 hasAuthorship W2889968197A5029935476 @default.
• W2889968197 hasAuthorship W2889968197A5053179795 @default.
• W2889968197 hasAuthorship W2889968197A5055173181 @default.
• W2889968197 hasAuthorship W2889968197A5057926104 @default.
• W2889968197 hasAuthorship W2889968197A5061095811 @default.
• W2889968197 hasAuthorship W2889968197A5067193136 @default.
• W2889968197 hasAuthorship W2889968197A5071060598 @default.
• W2889968197 hasAuthorship W2889968197A5080811290 @default.
• W2889968197 hasAuthorship W2889968197A5081355165 @default.
• W2889968197 hasAuthorship W2889968197A5082094987 @default.
• W2889968197 hasAuthorship W2889968197A5084629809 @default.
• W2889968197 hasAuthorship W2889968197A5088690292 @default.
• W2889968197 hasAuthorship W2889968197A5089708987 @default.
• W2889968197 hasAuthorship W2889968197A5091765229 @default.
• W2889968197 hasConcept C126322002 @default.
• W2889968197 hasConcept C126894567 @default.
• W2889968197 hasConcept C143998085 @default.
• W2889968197 hasConcept C2777472916 @default.
• W2889968197 hasConcept C2780091579 @default.
• W2889968197 hasConcept C2780227381 @default.
• W2889968197 hasConcept C71924100 @default.
• W2889968197 hasConceptScore W2889968197C126322002 @default.
• W2889968197 hasConceptScore W2889968197C126894567 @default.
• W2889968197 hasConceptScore W2889968197C143998085 @default.
• W2889968197 hasConceptScore W2889968197C2777472916 @default.
• W2889968197 hasConceptScore W2889968197C2780091579 @default.
• W2889968197 hasConceptScore W2889968197C2780227381 @default.
• W2889968197 hasConceptScore W2889968197C71924100 @default.
• W2889968197 hasLocation W28899681971 @default.
• W2889968197 hasOpenAccess W2889968197 @default.
• W2889968197 hasPrimaryLocation W28899681971 @default.
• W2889968197 isParatext "false" @default.
• W2889968197 isRetracted "false" @default.
• W2889968197 magId "2889968197" @default.
• W2889968197 workType "article" @default.